The tachykinin NK₁ receptor. Part II: distribution and pathophysiological rolesQUARTARA, L; MAGGI, C. A.Neuropeptides (Edinburgh). 1998, Vol 32, Num 1, pp 1-49, issn 0143-4179Article

Cyclosporin A is a substance P (tachykinin NK₁) receptor antagonistGITTER, B. D; WATERS, D. C; THRELKELD, P. G et al.European journal of pharmacology. Molecular pharmacology section. 1995, Vol 289, Num 3, pp 439-446, issn 0922-4106Article

The role of the amino-terminal domain of tachykinins in neurokinin-1 receptor signaling and desensitizationVIGNA, Steven R.Neuropeptides (Edinburgh). 2003, Vol 37, Num 1, pp 30-35, issn 0143-4179, 6 p.Article

Tachykinin NK₁ receptor antagonistsPATACCHINI, R; MAGGI, C. A.Handbook of experimental pharmacology. 2004, Vol 164, pp 173-218, issn 0171-2004, 46 p.Article

Synthesis and biological activity of NK₁ tachykinin antagonists not containing D-residuesPOULOS, C; ANTONIOU, M; PATACCHINI, R et al.Neuropeptides (Edinburgh). 1994, Vol 26, Num 1, pp 55-57, issn 0143-4179Article

Substance P-evoked calcium mobilization and ionic current activation in the human astrocytoma cell line U 373 MG : pharmacological characterizationPRADIER, L; HEUILLET, E; HUBERT, J. P et al.Journal of neurochemistry. 1993, Vol 61, Num 5, pp 1850-1858, issn 0022-3042Article

Rolapitant for the Prevention of Postoperative Nausea and Vomiting: A Prospective, Double-Blinded, Placebo-Controlled Randomized TrialGAN, Tong J; JIEZHUN GU; CREED, Mary R et al.Anesthesia and analgesia. 2011, Vol 112, Num 4, pp 804-812, issn 0003-2999, 9 p.Article

Substance P (NK₁) receptor antagonists-analgesics or not?BOYCE, S; HILL, R. G.Handbook of experimental pharmacology. 2004, Vol 164, pp 441-457, issn 0171-2004, 17 p.Article

Inflammation-induced up-regulation of neurokinin 1 receptors in rat glabrous skinCARLTON, Susan M; COGGESHALL, Richard E.Neuroscience letters. 2002, Vol 326, Num 1, pp 29-32, issn 0304-3940Article

NK₁ and NK₂ receptors are similar in man and rabbitCOGE, F; REGOLI, D.Neuropeptides (Edinburgh). 1994, Vol 26, Num 6, pp 385-390, issn 0143-4179Article

SR 140333, a novel, selective, and potent nonpeptide antagonist of the NK1 tachykinin receptor : characterization on the U373MG cell lineOURY-DONAT, F; LEFEVRE, I. A; THURNEYSSEN, O et al.Journal of neurochemistry. 1994, Vol 62, Num 4, pp 1399-1407, issn 0022-3042Article

Generation of a transgenic model to address regulation and function of the human neurokinin 1 receptor (NK1R)VASILIOU, A. S; MACKENZIE, A; MORRIS, R et al.Neuropeptides (Edinburgh). 2007, Vol 41, Num 4, pp 195-205, issn 0143-4179, 11 p.Article

Conversion of antagonist-binding site to metal-ion site in the tachykinin NK-1 receptorELLING, C. E; MØLLER NIELSEN, S; SCHWARTZ, T. W et al.Nature (London). 1995, Vol 374, Num 6517, pp 74-77, issn 0028-0836Article

Quinuclidine based NK-1 antagonists. II: Determination of the absolute stereochemical requirementsSWAIN, C. J; SEWARD, E. M; SABIN, V et al.Bioorganic & medicinal chemistry letters (Print). 1993, Vol 3, Num 8, pp 1703-1706, issn 0960-894XArticle

Stress-induced increase of cortical dopamine metabolism: attenuation by a tachykinin NK₁ receptor antagonistHUTSON, Peter H; PATEL, Shil; JAY, Mark T et al.European journal of pharmacology. 2004, Vol 484, Num 1, pp 57-64, issn 0014-2999, 8 p.Article

Pharmacology of MEN 11467 : a potent new selective and orally-effective peptidomimetic tachykinin NK₁ receptor antagonistCIRILLO, R; ASTOLFI, M; MAGGI, C. A et al.Neuropeptides (Edinburgh). 2001, Vol 35, Num 3-4, pp 137-147, issn 0143-4179Article

A water-soluble, stable dipeptide NK₁ receptor-selective neurokinin receptor antagonist with potent in vivo pharmacological effects : S18523BONNET, J; KUCHARCZYK, N; ROBINEAU, P et al.European journal of pharmacology. 1996, Vol 310, Num 1, pp 37-46, issn 0014-2999Article

Investigation of the specificity of FK 888 as a tachykinin NK₁ receptor antagonistZUN-YI WANG; TUNG, S. R; STRICHARTZ, G. R et al.British journal of pharmacology. 1994, Vol 111, Num 4, pp 1342-1346, issn 0007-1188Article

Differences in the expression of neurokinin receptor in neural and bone marrow mesenchymal cells: implications for neuronal expansion from bone marrow cellsBANDARI, P. S; QIAN, J; YEHIA, G et al.Neuropeptides (Edinburgh). 2002, Vol 36, Num 1, pp 13-21, issn 0143-4179Article

Comparison of tachykinin NK₁ receptors in human IM9 and U373 MG cells, using antagonist (FK888, (±)-CP-96,345, and RP 67580) bindingGOSO, C; POTIER, E; MANZINI, S et al.European journal of pharmacology. 1994, Vol 254, Num 3, pp 221-227, issn 0014-2999Article

LOSS OF NEURONS IN ROSTRAL VENTROMEDIAL MEDULLA THAT EXPRESS NEUROKININ-1 RECEPTORS DECREASES THE DEVELOPMENT OF HYPERALGESIAKHASABOV, S. G; SIMONE, D. A.Neuroscience. 2013, Vol 250, pp 151-165, issn 0306-4522, 15 p.Article

Synergistic antiemetic interactions between serotonergic 5-HT₃ and tachykininergic NK₁-receptor antagonists in the least shrew (Cryptotis parva)DARMANI, Nissar A; CHEBOLU, Seetha; AMOS, Barry et al.Pharmacology, biochemistry and behavior. 2011, Vol 99, Num 4, pp 573-579, issn 0091-3057, 7 p.Article

Antiemesis After Total Joint Arthroplasty: Does a Single Preoperative Dose of Aprepitant Reduce Nausea and Vomiting? : Complications of hip arthroplastyDILORIO, Timothy M; SHARKEY, Peter F; HEWITT, Agnes M et al.Clinical orthopaedics and related research. 2010, Vol 468, Num 9, pp 2405-2409, issn 0009-921X, 5 p.Article

Artificial microRNA-based neurokinin-1 receptor gene silencing reduces alcohol consumption in miceMI NA BAEK; KYOUNG HWA JUNG; YOUNG GYU CHAI et al.Neuroscience letters. 2010, Vol 475, Num 3, pp 124-128, issn 0304-3940, 5 p.Article

Substance P neurotransmission and violent aggression: The role of tachykinin NK₁ receptors in the hypothalamic attack areaHALASZ, Jozsef; ZELENA, Dora; TOTH, Mate et al.European journal of pharmacology. 2009, Vol 611, Num 1-3, pp 35-43, issn 0014-2999, 9 p.Article